Irvine, CA–January 11-15, 2021–Modulim is participating in Digital Medicine & Medtech Showcase 2021, part of Biotech Showcase™ 2021, and providing an on-demand company presentation. This year registered attendees to Digital Medicine & Medtech Showcase are able to access recorded company presentations, on-demand access allows attendees to view presentations at their convenience, avoiding conflicts with busy meeting schedules during the main event week.
Charlie Huiner, President and CEO will be presenting Modulim at Digital Medicine & Medtech Showcase Digital.
Modulim’s recently launched and FDA cleared Clarifi® Imaging solutions are well positioned to help healthcare providers diagnose and treat patients with diabetes and peripheral arterial disease who are at risk for lower limb complications. It is estimated that $237B is spent the US alone on diabetes care, of which $60B is directly related to lower limb care. Modulim is on the forefront of technology that enables preventive care for diabetic foot ulcers (DFUs) and related complications, decreasing the cost for health systems.
To support the company’s rapid growth strategy, Charlie Huiner, President and CEO, recently joined Modulim to help direct a focused commercial execution plan and secure the next round of funding needed to scale operations. Charlie brings broad and deep business experience in developing and commercializing a wide range of new and complex medical technologies.
“Modulim is pleased to be participating in the Digital Medicine & Medtech Showcase this year,” said Charlie Huiner, President & CEO of Modulim. “This is an exciting time for the Company and we look forward to using this venue to share the commercialization opportunity for our initial product solution to help detect and proactively treat lower limb vascular complications,” Huiner continued. “We are actively seeking collaborative capital partners who understand the significant unmet need that our technology addresses and who are ready to join us and our existing addresses and who are ready to join us and our existing partners in expanding the benefits of our Clarifi imaging and analytics solutions to those suffering from these chronic conditions.”
Digital Medicine & Medtech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on providing the very latest in digital medicine, medtech innovations, and cutting-edge technologies. It helps drive advances by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference is part of the Biotech Showcase family of events, which takes place each year during the course of one of the industry’s largest gatherings and busiest weeks.
“We are delighted that Modulim will be at Digital Medicine & Medtech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “The Digital Medicine & Medtech Showcase is a prime occasion for digital medicine and medtech entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of healthcare.”
ABOUT DIGITAL MEDICINE & MEDTECH SHOWCASE
Digital Medicine & Medtech Showcase, part of the Biotech Showcase family of events, is an investor and networking conference devoted to providing private and public digital medicine and medtech companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this bellwether week which sets the tone for the coming year. Now in its 5th year, Digital Medicine & Medech Showcase is a well-established, highly respected conference featuring multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Digital Medicine & Medtech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
Modulim is a privately held medical device company founded by the inventors of SFDI at the University of California Irvine with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Its mission is to deliver transformative optical solutions that help people live healthier, longer lives. Clarifi®, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Clarifi Imaging System is an FDA cleared and CE Marked product. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK. Clarifi is a registered trademark of Modulated Imaging (dba Modulim).
VP Sales and Marketing